类风湿关节炎较非炎性风湿肌肉骨骼病严重感染风险更高
RA的SI发生率更高(IRR=1.5;95%CI 1.2~1.5),经LASSO模型校正后仍升高(HR 1.7;95%CI 1.5~1.8),进一步校正糖皮质激素使用后减弱(HR 1.3;95%CI 1.2~1.5);疾病活动度中高者风险升高,低活动/缓解者与NIRMD相似。
要点
- RA患者严重感染风险高于NIRMD,细菌性及呼吸道、血流、脓毒症、皮肤、骨关节感染均升高。
- 校正糖皮质激素使用后RA的SI风险增幅减弱,提示激素使用是重要混杂因素。
- RA中高疾病活动度者SI风险显著升高,低活动/缓解者与NIRMD相似。
核心结论
- 与NIRMD相比,RA患者所有严重感染风险显著升高,尤其细菌性、呼吸道、血流、脓毒症、皮肤、骨与关节感染。
- RA的感染风险在中高疾病活动度患者中最高,低疾病活动/缓解者与NIRMD相似。
研究设计与样本
- 采用Cox比例风险模型,并以机器学习LASSO方法选择最佳模型。
主要发现
- RA与NIRMD分别识别出1600例和276例首次严重感染。
- RA的SI发生率高于NIRMD(IRR=1.5;95%CI 1.2~1.5)。
- LASSO模型校正后风险持续(HR 1.7;95%CI 1.5~1.8),额外校正糖皮质激素使用后减弱(HR 1.3;95%CI 1.2~1.5)。
- 无论是否使用糖皮质激素,RA的细菌感染及呼吸道、皮肤、骨、关节、血流感染和脓毒症风险均显著高于NIRMD。
- 与NIRMD相比,中高疾病活动度RA患者SI风险显著升高,低活动/缓解者相似(p trend < 0.001)。
关键数值与推荐
- 严重感染定义:需住院、静脉抗生素或随后死亡的感染。
- RA vs NIRMD的SI发生率比IRR=1.5(95%CI 1.2~1.5)。
- LASSO校正后HR 1.7(95%CI 1.5~1.8),额外校正糖皮质激素后HR 1.3(95%CI 1.2~1.5)。
- 疾病活动度与SI风险关联的p trend < 0.001。
临床怎么用
- 对RA患者应评估严重感染风险,尤其关注中高疾病活动度者。
- 管理RA时需权衡糖皮质激素使用对感染风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify serious infection (SI) risk by aetiology and site in patients with rheumatoid arthritis (RA) compared with those with non-inflammatory rheumatic and musculoskeletal diseases (NIRMD). METHODS: Patients participating in FORWARD from 2001 to 2016 were assessed for SIs; defined by infections requiring hospitalisation, intravenous antibiotics or followed by death. SIs were categorised by aetiology and site. SI risk was assessed through Cox proportional hazards models. Best models were selected using machine learning Least Absolute Shrinkage and Selection Operator (LASSO) methodology. RESULTS: Among 20 361 patients with RA and 6176 patients with NIRMD, 1600 and 276 first SIs were identified, respectively. Incidence of SIs was higher in RA compared with NIRMD (IRR = 1.5; 95% CI 1.2 to 1.5). The risk persisted after adjusting using the LASSO model (HR 1.7; 95% CI 1.5 to 1.8), but attenuated when additionally adjusted for glucocorticoid use (HR 1.3; 95% CI 1.2 to 1.5). SI risk was significantly higher in RA versus NIRMD for bacterial infections as well as for respiratory, skin, bone, joint, bloodstream infections and sepsis irrespective of glucocorticoid use. Compared with NIRMD, SI risk was significantly increased in patients with RA who were in moderate and high disease activity but was similar to those in low disease activity/remission (p trend < 0.001). CONCLUSIONS: The risk of all SIs, particularly bacterial, respiratory, bloodstream, sepsis, skin, bone and joint infections are significantly increased in patients with RA compared with patients with NIRMD. This infection risk appears to be greatest in those with higher RA disease activity.
引用
- Mehta B, Pedro S, Ozen G, et al. Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study. RMD Open. 2019. PMID: 31245055. doi:10.1136/rmdopen-2019-000935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。